Cargando…

mRNA-based vs viral vector-based COVID-19 vaccines

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435127/
http://dx.doi.org/10.1007/s40278-021-01937-y
_version_ 1783751727563931648
collection PubMed
description
format Online
Article
Text
id pubmed-8435127
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-84351272021-09-13 mRNA-based vs viral vector-based COVID-19 vaccines Reactions Weekly Clinical Study Springer International Publishing 2021-09-11 2021 /pmc/articles/PMC8435127/ http://dx.doi.org/10.1007/s40278-021-01937-y Text en © Springer International Publishing AG 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Clinical Study
mRNA-based vs viral vector-based COVID-19 vaccines
title mRNA-based vs viral vector-based COVID-19 vaccines
title_full mRNA-based vs viral vector-based COVID-19 vaccines
title_fullStr mRNA-based vs viral vector-based COVID-19 vaccines
title_full_unstemmed mRNA-based vs viral vector-based COVID-19 vaccines
title_short mRNA-based vs viral vector-based COVID-19 vaccines
title_sort mrna-based vs viral vector-based covid-19 vaccines
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435127/
http://dx.doi.org/10.1007/s40278-021-01937-y